Becoming Without: Making Transgenic Mosquitoes and Disease Control in Brazil
By Luísa Reis-Castro,
Duke University Press
| 11. 01. 2021
The First Bite
At the end of a day of fieldwork in Juazeiro, a city in Northeast Brazil, I sat in bed trying to write up my notes. A noisy fan in my small room was not alleviating the suffocating heat, so I moved to the porch to breath in some fresh air. Not long after I sat down, an itch on my left arm prompted a quick swat from my right hand. I turned my hand over to see a dead mosquito, with blood smeared on my skin. During my stay in Juazeiro, in the semiarid region of the Bahia state, mosquitoes, which in this region are broadly called muriçocas, were a constant presence. The itchiness caused by their bites is a nuisance, but they can also be dangerous: some mosquitoes convey disease pathogens. As I inspected the dead mosquito that afternoon my trained eye recognized its black-and-white stripes as a telltale signature of the Aedes aegypti, a species notorious for transmitting viruses such as dengue, chikungunya, Zika, and (urban) yellow fever.
It was the A. aegypti...
Related Articles
Flag of South Africa; design by Frederick Brownell,
image by WikimediaCommons users.
Public domain, via Wikimedia Commons
What is the legal status of heritable human genome editing (HHGE)? In 2020, a comprehensive policy analysis by Baylis, Darnovsky, Hasson, and Krahn documented that more than 70 countries and an international treaty prohibit it, and that no country explicitly permits it. Policies in some countries were non-existent, ambiguous, or subject to possible amendment, but the general rule remained, even after one...
By Bernice Lottering, Gene Online | 11.08.2024
South Africa’s updated health-research ethics guidelines, which now include heritable human genome editing, have sparked concern among scientists. The revisions, made in May but only recently gaining attention, outline protocols for modifying genetic material in sperm, eggs, or embryos—changes that...
By Jim Thomas, Scan the Horizon | 11.19.2024
It’s the wee hours of 2nd November 2024 in Cali, Colombia. In a large UN negotiating hall Colombian Environment Minister Susana Muhamed has slammed down the gavel on a decision that should send a jolt through the AI policy world. ...
By Ned Pagliarulo, BioPharmaDive | 11.05.2024
A medicine built around a more precise form of CRISPR gene editing appeared to work as designed in its first clinical trial test, developer Beam Therapeutics said Tuesday. But the death of a trial participant could renew concerns about an older...